###begin article-title 0
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Mutations in the DNA-Binding Domain of NR2E3 Affect In Vivo Dimerization and Interaction with CRX
###end article-title 0
###begin p 1
Conceived and designed the experiments: RR PAE. Performed the experiments: RR PAE. Analyzed the data: RR. Contributed reagents/materials/analysis tools: DFS. Wrote the paper: RR PAE DFS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 115 121 <span type="species:ncbi:9606">humans</span>
NR2E3 (PNR) is an orphan nuclear receptor essential for proper photoreceptor determination and differentiation. In humans, mutations in NR2E3 have been associated with the recessively inherited enhanced short wavelength sensitive (S-) cone syndrome (ESCS) and, more recently, with autosomal dominant retinitis pigmentosa (adRP). NR2E3 acts as a suppressor of the cone generation program in late mitotic retinal progenitor cells. In adult rod photoreceptors, NR2E3 represses cone-specific gene expression and acts in concert with the transcription factors CRX and NRL to activate rod-specific genes. NR2E3 and CRX have been shown to physically interact in vitro through their respective DNA-binding domains (DBD). The DBD also contributes to homo- and heterodimerization of nuclear receptors.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 674 683 674 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodospin</italic>
###xml 804 806 804 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-</italic>
###xml 811 818 811 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-opsin</italic>
We analyzed NR2E3 homodimerization and NR2E3/CRX complex formation in an in vivo situation by Bioluminescence Resonance Energy Transfer (BRET2). NR2E3 wild-type protein formed homodimers in transiently transfected HEK293T cells. NR2E3 homodimerization was impaired in presence of disease-causing mutations in the DBD, except for the p.R76Q and p.R104W mutant proteins. Strikingly, the adRP-linked p.G56R mutant protein interacted with CRX with a similar efficiency to that of NR2E3 wild-type and p.R311Q proteins. In contrast, all other NR2E3 DBD-mutant proteins did not interact with CRX. The p.G56R mutant protein was also more effective in abolishing the potentiation of rhodospin gene transactivation by the NR2E3 wild-type protein. In addition, the p.G56R mutant enhanced the transrepression of the M- and S-opsin promoter, while all other NR2E3 DBD-mutants did not.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
These results suggest different disease mechanisms in adRP- and ESCS-patients carrying NR2E3 mutations. Titration of CRX by the p.G56R mutant protein acting as a repressor in trans may account for the severe clinical phenotype in adRP patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Hennig1">[2]</xref>
###xml 567 570 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Haider1">[3]</xref>
###xml 671 674 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 676 679 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Chen1">[5]</xref>
###xml 746 749 746 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 751 754 751 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Cheng1">[6]</xref>
###xml 756 759 756 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Cheng2">[7]</xref>
NR2E3 (MIM#604485) is a photoreceptor-specific nuclear receptor (PNR) that belongs to the nuclear hormone receptor superfamily of ligand-modulated transcription factors [1]. The physiological function of NR2E3 is to regulate the proper differentiation and maturation of rod and cone photoreceptors, in an intricate regulatory network including the cone-rod homeobox (CRX) (MIM#602225) and the neural retina leucine zipper (NRL) (MIM#162080) transcription factors [2]. In late mitotic retinal progenitor cells, NR2E3 is thought to suppress the cone generation program [3], while in adult differentiated rods, NR2E3 exerts a dual function by repressing cone-specific genes [4], [5] and by activating several rod-specific genes, including rhodopsin [4], [6], [7].
###end p 9
###begin p 10
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Mangelsdorf1">[8]</xref>
###xml 319 320 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 557 559 557 559 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EG</underline>
###xml 561 562 561 562 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 567 569 567 569 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EG</underline>
###xml 571 572 571 572 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 610 613 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 671 673 671 673 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NG</underline>
###xml 675 676 675 676 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 699 701 699 701 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DG</underline>
###xml 703 704 703 704 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 792 798 792 798 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAGTCA</named-content>
###xml 798 801 798 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 803 806 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Pankratz1">[9]</xref>
###xml 871 872 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
All nuclear receptors (NRs) share a common structural organization composed of four main domains [8]. First, the highly variable N-terminal A/B domain comprises a ligand-independent activation function (AF-1). Second, the most conserved C domain forms a 70-amino acid long DNA-binding domain (DBD) consisting of two Cys4 zinc fingers. The C-terminus of the first Cys4 zinc finger comprises the so-called P-box that specifically contacts nucleotides located in the DNA major groove. Three discriminatory amino acids (underlined below) determine DNA binding, EGCKS and EGCKG in NR2 family members and orphan NRs [1]. NR2E subfamily members exhibit exceptional P-boxes with NGCSG sequence in NR2E3 and DGCSG in NR2E1 and NR2E2. The consensus core motif recognized by NR2E proteins appears to be AAGTCA[1], [9]. The region between the first two Cys residues of the second Cys4 zinc finger forms the so-called D-box, which is involved in DBD dimerization and recognition of the spacing between two adjacent core motifs. Third, the flexible D domain, or so-called hinge domain, links the DBD to the ligand-binding domain (LBD) and contains the nuclear localization signal which may overlap on the DBD. Fourth, the C-terminal E/F domain, or LBD, consists of a conserved secondary structure formed by 12 alpha-helixes, containing a strong dimerization function and the ligand-dependent AF-2 transactivation function.
###end p 10
###begin p 11
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Owen1">[10]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Yu1">[11]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Yu2">[12]</xref>
###xml 583 591 583 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 763 799 763 799 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-(A/G)AG(A/G)TCAAA(A/G)(A/G)TCA-3&#8242;</named-content>
###xml 799 802 799 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Chen1">[5]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Yu2">[12]</xref>
###xml 287 297 <span type="species:ncbi:7227">Drosophila</span>
###xml 323 328 <span type="species:ncbi:9031">chick</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
The first NRs most likely acted as monomers in a ligand-independent fashion [10]. NRs then acquired the ability to homo- or heterodimerize and to interact with specific ligands, allowing the regulation of more diverse and more complex physiological processes. Within the NR2E subfamily, Drosophila tailless (NR2E2) and its chick and mouse orthologs Tlx (NR2E1) bind their target genes as monomers [11], [12]. Homodimers have also been reported to bind DNA, but to a lesser extent. Interestingly, NR2E3 also acts as a transcriptional repressor (see above), but, in contrast to NR2E1, in vitro DNA binding experiments suggested binding to a direct repeat of the core motif spaced by one nucleotide (so-called DR1 response element), the consensus binding site being 5'-(A/G)AG(A/G)TCAAA(A/G)(A/G)TCA-3'[1], [5]. It is therefore tempting to speculate that in addition to unique P-box and D-box sequences and to a spatial expression uniquely restricted to photoreceptors, NR2E3 dimer formation can increase target specificity when compared to NR2E1, another NR expressed in the retina [12].
###end p 11
###begin p 12
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Haider2">[13]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Jacobson1">[14]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Haider2">[13]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Milam1">[15]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Schorderet1">[19]</xref>
###xml 590 591 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Coppieters1">[20]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Gire1">[22]</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans, mutations in NR2E3 have first been associated with the recessively inherited enhanced short wavelength sensitive (S-) cone syndrome (ESCS) (MIM #268100) [13]. ESCS is characterized by unique full-field and spectral electroretinographic findings with hyperfunction of S-cones ('blue' cones) and impaired M-cones, L-cones and rods function [14]. To date, 32 different mutations located in the evolutionary-conserved DBD and LBD of NR2E3 have been linked to ESCS with c.932G>A (p.R311Q) being the most prevalent [13], [15]-[19]. A c.166G>A (p.G56R) mutation located in the first Cys4 zinc finger of NR2E3 gene was shown to cause autosomal dominant (ad) retinitis pigmentosa (RP) (adRP), termed RP37 (MIM #611131) [20]-[22]. The phenotype corresponded to that seen in classic adRP, with progressive degeneration of rods and subsequent involvement of cones.
###end p 12
###begin p 13
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Hamdan1">[23]</xref>
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Storez1">[27]</xref>
###xml 263 272 263 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Schorderet1">[19]</xref>
###xml 609 614 <span type="species:ncbi:9606">human</span>
###xml 615 623 <span type="species:ncbi:9606">patients</span>
In this study, we analysed by Bioluminescence Resonance Energy Transfer 2 (BRET2) [23]-[27], NR2E3 homodimerization and interaction with CRX for all reported NR2E3 mutations located in the DBD. Transcriptional activity of the different mutants was also tested on rhodopsin, S- and M-opsin promoter reporter constructs. These analyses showed a distinct in vivo protein-protein interaction of the adRP-linked p.G56R mutant protein with CRX, comparable to that of wild-type NR2E3, but contrasting with the other ESCS-linked DBD mutants. This provided a novel molecular basis for the clinical differences seen in human patients affected by adRP versus those affected by ESCS [19].
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
NR2E3 homodimerization in HEK293T cells
###end title 15
###begin p 16
###xml 248 257 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figure 1A</xref>
###xml 536 543 536 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
To analyze a potential dimerization of NR2E3, we expressed the human NR2E3 wild-type protein by transient transfection in heterologous HEK293T cells. Total protein extracts were separated by SDS-PAGE under denaturing and non-denaturing conditions (figure 1A). Western blot analysis with an anti-NR2E3 antibody detected a band of the expected size at 45 kDa under denaturing conditions, while a fainter additional reactive band was observed at 90 kDa under native conditions. This result suggested that NR2E3 was able to form homodimers in vivo.
###end p 16
###begin title 17
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
NR2E3 homodimerization analyzed by Western blot and Bioluminescence Resonance Energy Transfer (BRET2).
###end title 17
###begin p 18
###xml 439 440 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 525 526 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 537 538 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 574 575 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 704 705 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 724 725 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 775 776 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 805 806 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1114 1115 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1200 1201 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1201 1208 1193 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 1279 1280 1269 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1288 1291 1278 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1321 1322 1311 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1335 1336 1325 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1394 1395 1384 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A) HEK293T cells were transiently transfected in 60-mm plates with either 3 microg of an empty pcDNA3 vector or a pcDNA-NR2E3-His/C vector. Forty-eight hours after transfection, cell lysates were separated on a 8% PAA-gel in both non-denaturing (left panel) and denaturing (right panel) conditions. NR2E3 was immunodetected by Western blot with an anti-NR2E3 antibody. Molecular weights are indicated on the left side in kDa. B-C) For BRET2 analysis, HEK293T cells were transiently transfected with 3 microg of RLuc, RLuc/GFP2-NR2E3, GFP2-NR2E3/NR2E3-RLuc and NR2E3-RLuc/GFP2 vectors. B) GFP fluorescence and localization analysis by fluorescence microscopy in cells transfected with RLuc, NR2E3-RLuc/GFP2 and NR2E3-RLuc/GFP2-NR2E3. C) NR2E3 homodimerization analyzed by BRET2 48 h after transfection. GFP2 fluorescence was quantified at 515 nm after an excitation at 485 nm (upper graph in black bars). After addition of the renilla luciferase substrate, Coelanterazine h luciferase luminescence was measured (middle graph in white bars). Fluorescence and luminescence levels are in arbitrary units. Finally, BRET2 ratio was measured in the four different conditions (lower graph in grey bars). BRET2sesults were expressed as mean+/-SEM of 3 experiments, p<0.003 (NR2E3-RLuc/GFP2-NR2E3) vs. both controls (NR2E3-RLuc/GFP2 and RLuc/GFP2-NR2E3). Protein expression of NR2E3 fused either with GFP2 (GFP-NR2E3: 74 kDa) or RLuc (NR2E3-RLuc: 82 kDa) was assessed by Western blot analysis. We used a 10% PAA-gel to separate proteins and an anti-NR2E3 antibody to detect NR2E3 fusion proteins (panel, below).
###end p 18
###begin p 19
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 437 438 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 446 455 446 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">Figure 1B</xref>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 657 658 657 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 720 721 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 770 771 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 838 839 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 964 986 964 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figure 1C, upper panel</xref>
###xml 1158 1181 1158 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figure 1C, middle panel</xref>
###xml 1330 1331 1330 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1343 1361 1343 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material &amp; Methods</xref>
###xml 1431 1432 1431 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1455 1477 1455 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figure 1C, lower panel</xref>
###xml 1509 1510 1509 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1564 1565 1564 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1575 1576 1575 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To analyze the dimerization of NR2E3 in vivo, we resorted to the BRET2 technique. We transiently transfected HEK293T cells with vectors expressing the Renilla Luciferase (RLuc) fused to the C-terminus of NR2E3 (NR2E3-RLuc) and the Green Fluorescent Protein (GFP2) fused to the N-terminus of NR2E3 (GFP2-NR2E3). As negative controls, cells were transfected with vectors expressing 1) RLuc alone, 2) GFP2 and NR2E3-RLuc and 3) RLuc and GFP2-NR2E3. Figure 1B showed the both negative controls 1 and 2, and positive experiment. Moreover, this fluorescence imaging showed that the GFP2-NR2E3 fusion protein was correctly localized to the nucleus, whereas the GFP2 protein showed both cytosolic and nuclear expression. By BRET2 analysis, we were able to measure comparable GFP2 fluorescence levels in cells expressing either the GFP2 or the GFP2-NR2E3 proteins, whereas low fluorescence levels were observed in controls transfected only with the RLuc expression vector (figure 1C, upper panel). In addition, when the Renilla Luciferase substrate, coelanterazine h, was added to the cells, we observed similar levels of luminescence in all experimental conditions (figure 1C, middle panel). These data confirmed that similar levels of protein expression occurred in both control and experimental conditions. Finally, we measured the BRET2 ratio (see Material & Methods) and observed a significant increase only in the presence of both GFP2-NR2E3 and NR2E3-RLuc (figure 1C, lower panel). In controls, where either GFP2-NR2E3 was expressed with RLuc, or NR2E3-RLuc with GFP2, the BRET2 ratios were very low.
###end p 19
###begin p 20
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 453 454 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 609 618 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g002">figure 2A</xref>
We then tested whether NR2E3 dimer formation was dependent upon the localization of the donor (GFP2) or the acceptor (RLuc) protein in the NR2E3 fusion protein. We transfected HEK293T cells with vectors expressing NR2E3 fused to the N-terminus or the C-terminus of either GFP2 or RLuc. Again, a significant increase in BRET2 ratios was observed in presence of all combinations of NR2E3 fusion proteins, while protein expression levels (NR2E3-GFP2 or GFP2-NR2E3 fluorescence) were comparable in each condition. These results suggested that the orientation of the fusions was not interfering with dimerization (figure 2A).
###end p 20
###begin title 21
NR2E3 homodimerization is orientation-independent.
###end title 21
###begin p 22
###xml 72 73 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 78 79 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 221 222 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 233 234 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 242 243 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 256 257 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 285 286 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 333 340 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 396 399 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 676 677 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 696 697 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 721 728 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 786 808 766 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s001">supplemental figure 1A</xref>
###xml 847 848 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A) HEK293T cells were transiently transfected with 3 microg of NR2E3-GFP2, GFP2-NR2E3, NR2E3-RLuc and RLuc-NR2E3 vectors, as indicated. Control transfections were performed with renilla alone (RLuc) and NR2E3 fused to GFP2 (NR2E3-GFP2 and GFP2-NR2E3). BRET2 ratio (grey column) and GFP2 fluorescence (black column) were measured and sesults were expressed as mean+/-SEM of 3 experiments, p<0.003 vs. controls. B) HEK293T cells were transiently transfected with 3 microg of RLuc or NR2E3-RLuc vectors, to keep the expression level of both proteins stable in each condition. At the same time, cells were transfected with increasing concentrations (0.5 microg to 3 microg) of GFP2-NR2E3 vector. BRET2 ratio was measured and sesults were expressed as mean+/-SEM of 4 experiments. (see also supplemental figure 1A). C) Protein expression of various GFP2-NR2E3 concentrations was assessed by Western blot analysis using an anti-GFP antibody.
###end p 22
###begin p 23
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 168 182 168 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g002">figures 2B, 2C</xref>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To exclude the possibility that the increase in BRET2 ratios was due to non-specific interactions of overexpressed proteins, we performed a dose-dependency experiment (figures 2B, 2C and S1A). A constant amount of RLuc or RLuc-NR2E3 was expressed in the presence of increasing amounts of GFP2-NR2E3. In these conditions, we observed a dose-dependent increase of the BRET2 ratios, with a significant increase even at the lowest GFP2-NR2E3 expression levels (0.5 microg of expression vector). This further confirmed the specificity of the NR2E3 homodimerization.
###end p 23
###begin title 24
NR2E3/CRX interactions in HEK293T cells
###end title 24
###begin p 25
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 559 581 559 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figure 3A, upper panel</xref>
###xml 691 714 691 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figure 3A, middle panel</xref>
###xml 776 777 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 818 819 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 834 856 834 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figure 3A, lower panel</xref>
###xml 863 864 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 925 926 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 942 943 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 316 321 <span type="species:ncbi:9606">human</span>
As a physical interaction between NR2E3 and CRX through their respective DBDs was previous reported in vitro [4], we decided to analyze this interaction by BRET2 techniques. We transiently transfected HEK293T cells with vectors expressing GFP2 or NR2E3-GFP2, in presence of either RLuc or a fusion protein where the human CRX protein was fused in N-terminus of RLuc (Crx-RLuc). We were able to measure similar GFP2 fluorescence levels in cells expressing either GFP2 or NR2E3-GFP2, while low fluorescence levels were observed in control conditions with RLuc (figure 3A, upper panel). We observed a slight decrease in Renilla luminescence levels in presence of Crx-RLuc, as compared to RLuc (figure 3A, middle panel). Importantly, we observed a significant increase of the BRET2 ratio only in presence of both NR2E3-GFP2 and Crx-RLuc (figure 3A, lower panel). BRET2 ratios were lower in both control conditions (RLuc/NR2E3-GFP2 or Crx-RLuc/GFP2).
###end p 25
###begin title 26
NR2E3 interacts with CRX.
###end title 26
###begin p 27
###xml 77 78 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 89 90 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 122 123 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 137 138 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 214 215 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 453 454 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 602 603 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 608 609 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 747 748 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 759 760 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 768 769 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 782 783 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 813 814 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 900 903 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1163 1164 1141 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1177 1178 1155 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1202 1209 1180 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 1267 1270 1243 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1286 1308 1262 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s001">supplemental figure 1B</xref>
A) HEK293T cells were transiently transfected with 3 microg of RLuc, RLuc/GFP2-NR2E3, GFP2-NR2E3/Crx-RLuc and Crx-RLuc/GFP2 vectors. BRET2 analysis was performed 48 h after transfection. First we quantified the GFP2 fluorescence (at 515 nm) after an excitation at 485 nm (upper graph in black). Then, we added the renilla luciferase substrate, Coelanterazine h, to the cell and measured the luciferase luminescence (middle graph in white). Finally, BRET2 ratio was measured in the four different conditions (lower graph in grey). B) HEK293T cells were transiently transfected with 3 microg of NR2E3-GFP2, GFP2-NR2E3, Crx-RLuc and RLuc-Crx vectors, as indicated. Control transfections were performed with renilla alone (RLuc) and NR2E3 fused to GFP2 (NR2E3-GFP2 and GFP2-NR2E3). BRET2 results (grey column) and GFP2 fluorescence (black column) were expressed as mean+/-SEM of 2 experiments. *p<0.0001 vs. Ctrl. C) We transfected HEK293T cells with 3 microg of RLuc or Crx-RLuc vectors to keep the expression level of both proteins stable in each condition. At the same time, we transfected cells with increasing concentrations (0.5 microg to 2 microg) of NR2E3-GFP2 vector. BRET2 ratio was measured and sesults were expressed as mean+/-SEM of 3 experiments, *p<0.0001 vs. Ctrl (see also supplemental figure 1B).
###end p 27
###begin p 28
###xml 119 128 119 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figure 3B</xref>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
We then tested whether the localization of CRX in the fusion protein was important for NR2E3/CRX protein interactions (figure 3B). The highest BRET2 ratios, i.e. the most efficient NR2E3/CRX protein interactions, were obtained when CRX was located in the C-terminus of the renilla (RLuc-Crx), while this ratio was significantly decreased when CRX was fused to the N-terminus of RLuc (Crx-RLuc). Similar protein expression levels (NR2E3-GFP2 or GFP2-NR2E3 fluorescence) were observed in all performed conditions. These results showed that the orientation of the fusion proteins was important and suggested that the N-terminal part of CRX, where the DBD is located, had to be accessible for efficient NR2E3/CRX interactions.
###end p 28
###begin p 29
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 182 192 182 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figures 3C</xref>
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s001">S1B</xref>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 376 383 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We also performed a dose-dependency experiment, in presence of a constant amount of either RLuc or Crx-RLuc on the one hand, and, increasing amounts of NR2E3-GFP2 on the other hand (figures 3C and S1B). In this experiment, we observed a significant increase of the BRET2 ratio even at low amounts of NR2E3-GFP2 (0.5 microg). Taken together, these results confirmed a specific in vivo interaction between NR2E3 and CRX.
###end p 29
###begin title 30
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
BRET2 analysis of DBD mutations on NR2E3 dimerization and CRX interaction
###end title 30
###begin p 31
###xml 621 629 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s009">Table S1</xref>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 716 719 716 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 838 848 838 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s002">figures S2</xref>
###xml 853 856 853 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s003">S3A</xref>
To elucidate the molecular mechanisms by which mutations located in a same functional domain of NR2E3, i.e. the DBD, cause different clinical phenotypes, we chose to generate eight NR2E3 mutant proteins and tested their effect on dimerization. Seven of these mutations were localized in the DBD, i.e. the adRP-linked p.G56R mutation and the ESCS-linked p.R76Q, p.R76W, p.G88W, p.R97H, p.R104Q and p.R104W mutations. Additionally, we tested the common causal mutation for ESCS located in the LBD, p.R311Q. All mutations were introduced in the pcDNA3.1/HisC-hNR2E3 mammalian expression vector by site-directed mutagenesis (Table S1) and then subcloned into GFP2 vectors. The different NR2E3 mutant proteins (GFP2-NR2E3MUT) showed proper nuclear localization and protein expression levels as tested in transiently transfected HEK293T cells (figures S2 and S3A).
###end p 31
###begin p 32
###xml 120 122 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 204 207 204 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 210 219 210 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figure 4A</xref>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 415 425 415 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s003">figure S3A</xref>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 515 516 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s004">figure S4</xref>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To test whether these mutations altered the homodimerization of NR2E3, we expressed wild-type NR2E3 fused to RLuc (NR2E3WT-RLuc) in presence of equal amounts of each NR2E3 mutant fused to GFP2 (GFP2-NR2E3MUT) (figure 4A). For each experiment, we performed three control transfections: 1) RLuc alone to measure background fluorescence levels, 2) GFP2-NR2E3 and RLuc, and 3) NR2E3-RLuc and GFP2 as negative controls (figure S3A). Additionally, we performed a BRET2 titration curve for each NR2E3 mutant fused with GFP2 in presence of wild-type NR2E3 fused to RLuc or with RLuc alone as negative control (figure S4). The NR2E3 mutations differentially altered NR2E3 dimerization. In comparison to the NR2E3 wild-type protein, the BRET2 ratio was decreased by up to 70% in presence of the p.G56R, p.R76W, p.G88V, p.R97H and p.R104Q mutant proteins, thus indicating an impaired dimer formation. Interestingly, the p.R76Q mutation increased significantly dimerization (127.8+/-6.6%), whereas the p.R76W mutation dramatically decreased it (30.5+/-9.0%). In contrast, the p.R104Q mutation decreased dimerization (25.8+/-5.2%), whereas the p.R104W mutation increased it strongly (173.5+/-4.5%). The p.R311Q mutation located in the LBD did not alter dimerization, when compared to the wild-type NR2E3 protein.
###end p 32
###begin title 33
Role of NR2E3 DBD mutations in the dimerization process and in the interaction with CRX.
###end title 33
###begin p 34
###xml 141 143 137 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 219 220 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 225 226 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 232 235 224 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 279 280 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 286 288 278 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 329 330 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 386 406 378 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 412 419 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 446 447 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 453 455 445 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 461 463 453 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 535 556 525 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s004">supplemental figure 4</xref>
###xml 565 566 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 786 787 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 794 797 776 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 801 802 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 846 847 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 853 855 835 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 896 897 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 953 973 935 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 979 986 961 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 1015 1017 997 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 1021 1022 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1083 1104 1063 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s005">supplemental figure 5</xref>
###xml 1113 1114 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A) HEK293T cells were transiently transfected with 2 microg of vectors expressing the wild-type (WT) NR2E3 fused to renilla luciferase (NR2E3WT-RLuc) and with 4 microg vector expressing mutants of NR2E3 fused to the GFP2 (GFP2-NR2E3MUT). Control condition with RLuc alone and GFP2-NR2E3WT served to calculated the background BRET2 ratio. Luminescence ratio was measured as described in material and methods, and sesults were expressed as % of GFP2-NR2E3WT/NR2E3WT-RLuc and as mean+/-SEM of 3 experiments, * p<0.0001 and # p<0.01. (see supplemental figure 4 for BRET2 titration curve). B) HEK293T cells were transiently transfected with 2 microg of vectors expressing the CRX fused to renilla luciferase (Crx-RLuc) and with 4 microg of vector expressing mutants of NR2E3 fused to the GFP2 (NR2E3MUT-GFP2). Control condition with RLuc alone and GFP2-NR2E3WT served to calculated the background BRET2 ratio. Luminescence ratio was measured as described in material and methods, and sesults were expressed as % of NR2E3WT-GFP2/Crx-RLuc and as mean+/-SEM of 2 experiments, *p<0.003. (see supplemental figure 5 for BRET2 titration curve).
###end p 34
###begin p 35
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 249 252 249 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figure 4B</xref>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 431 441 431 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s003">figure S3B</xref>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 614 623 614 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s005">figure S5</xref>
Next, we resorted to the same experimental approach to test whether CRX/NR2E3 protein interactions were altered in presence of mutations in the NR2E3 DBD. We expressed Crx-RLuc in presence of an equal amount of each NR2E3 mutant fused to GFP2 (NR2E3MUT-GFP2) (figure 4B). For negative controls, cells were transfected with: 1) RLuc alone to measure background fluorescence levels, 2) GFP2-NR2E3 and RLuc, and 3) CRX-RLuc and GFP2 (figure S3B). Additionally, we performed a BRET2 titration curve for each NR2E3 mutant fused to GFP2 in presence of wild-type CRX fused to RLuc or with RLuc alone as negative control (figure S5). All ESCS-linked mutants, except p.R311Q, showed a significant decrease of interaction with CRX (50% or more). Remarkably, the CRX interaction of the adRP-linked p.G56R mutant was comparable to that of the NR2E3 wild-type protein.
###end p 35
###begin title 36
Mutations in the NR2E3 DBD abolish DNA binding
###end title 36
###begin p 37
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 292 298 292 298 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAGTCA</named-content>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 444 453 444 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s006">figure S6</xref>
We examined whether NR2E3 mutations affected DNA-binding. The pcDNA3.1/HisC-hNR2E3 wildtype and mutant plasmids were in vitro transcribed/translated in reticulocyte lysates and tested for DNA-binding by electrophoretic mobility-shift assay (EMSA) on the reported synthetic DR1 containing two AAGTCA half-sites [1]. No DNA-binding was observed for all seven DBD-mutants, whereas the p.R311Q LBD-mutant was able to bind the DNA response element (figure S6).
###end p 37
###begin title 38
Impaired transcriptional activity of NR2E3 DBD mutant proteins
###end title 38
###begin p 39
###xml 179 188 179 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 190 192 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 288 297 288 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 402 405 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 407 410 407 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Cheng2">[7]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
We then tested the effect of the NR2E3 mutant proteins on CRX/NRL-mediated transactivation by transient transfection assays in HEK293T cells. CRX and NRL synergistically activate rhodopsin, S- and M-opsin gene expression, and NR2E3 further potentiates CRX/NRL-mediated transactivation of rhodopsin expression by about 3-fold, but represses CRX/NRL-mediated transactivation of S- and M-opsin expression [4], [7], [21].
###end p 39
###begin p 40
###xml 77 86 77 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 246 255 246 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g005">figure 5A</xref>
###xml 304 306 304 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 312 315 312 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 530 532 530 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 542 551 542 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 593 595 593 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 601 605 601 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G56R</sub>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 687 689 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 695 699 695 699 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G56R</sub>
###xml 746 755 746 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 844 846 844 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 856 865 856 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 969 971 969 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 977 980 977 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 1042 1044 1042 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1065 1067 1065 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 1073 1076 1073 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 1186 1188 1186 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1290 1292 1290 1292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 1298 1303 1298 1303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R311Q</sub>
###xml 70 76 <span type="species:ncbi:9913">bovine</span>
NR2E3-dependent potentiation of CRX/NRL-mediated transactivation of a bovine rhodopsin promoter fragment (BR225-Luc) was set to 100% for each experiment, and, by transfecting increasing amounts of NR2E3 mutant proteins, we tested their effect on rhodopsin transactivation (figure 5A). The ratios of NR2E3WT:NR2E3MUT were 2:1, 2:2 and 2:3. NR2E3 mutant activity could be separated in three different groups, depending on the transactivation effect. First, the adRP-linked p.G56R mutant showed a highly significant decrease in NR2E3WT-mediated rhodopsin transactivation by 50% already at a NR2E3WT/NR2E3G56R ratio of 2:1 (p<0.01 by ANOVA test for p.G56R vs all other mutants). Higher NR2E3WT/NR2E3G56R ratios (2:2 and 2:3) did not further decrease rhodopsin promoter activity. Second, all six ESCS-linked DBD-mutants significantly repressed NR2E3WT-mediated rhodopsin transactivation, but to a lesser extent. Except for p.R104Q, this repression was significant at a NR2E3WT/NR2E3MUT ratio of 2:1 (p<0.05 by ANOVA of all ESCS-linked DBD mutants vs p.R311Q). At a NR2E3WT/NR2E3MUT ratio of 2:3, repression was significant for all DBD mutants (p<0.01 by ANOVA of all ESCS-linked DBD mutants vs p.R311Q,). Third, the LBD-mutation p.R311Q did not alter wild-type NR2E3 transactivation at any NR2E3WT/NR2E3R311Q ratio.
###end p 40
###begin title 41
Differential transcriptional activity of NR2E3 DBD mutants.
###end title 41
###begin p 42
###xml 48 57 48 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 141 143 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 354 355 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 686 688 683 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 843 850 840 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 1128 1130 1125 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 1165 1172 1162 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 1256 1259 1251 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
HEK293T cells were transiently transfected with rhodopsin (A) or S- and M-opsin (B) luciferase reporter constructs. A) NR2E3 wild-type (NR2E3WT), CRX and NRL expression vectors (30 ng each) were present in all wells. Transcriptional activity was tested in presence of increasing amounts (+:15 ng; ++:30 ng; +++:45 ng) of NR2E3-DBD mutants proteins (NR2E3m: p.G56R, p.R76Q, p.R76W, p.G88W, p.R97H, p.R104Q, p.R104W and p.R311Q). Four to six independent experiments were performed in duplicate in 12-well plates using the luciferase assay system (Promega). Luciferase activity was normalized to beta-galactosidase activity. Normalized luciferase activities of cells transfected with NR2E3WT, CRX and NRL were set to 100%. Error bars represent S.E.M. Regression curves were performed for each NR2E3-DBD mutant and ANOVA tests were performed (see Results section). B) NR2E3 wild-type (WT) or above-mentioned mutants, CRX and NRL expression vectors (30 ng each) were present in all wells except the negative control (-) representing the background luciferase activity. Normalized luciferase activities of cells transfected with NR2E3WT, CRX and NRL were set to 100% and sesults were expressed as means+/-SEM of 4-6 experiments, *p<0.0001 and #p<0.03 for p.G56R vs. WT.
###end p 42
###begin p 43
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 168 177 168 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g005">figure 5B</xref>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 409 411 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 506 513 506 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 632 634 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 639 646 639 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
With respect to repression of CRX/NRL-mediated transactivation of S- and M-opsin gene expression, the different NR2E3 mutations segregated into three different groups (figure 5B). First, the adRP-linked p.G56R mutant repressed both promoter fragment more efficiently than the NR2E3 wild-type protein, the resulting S- and M-opsin promoter activity being only about 50% of the wild-type one (p<0.0001 by ANOVA vs other mutants) [21]. Second, the ESCS-linked DBD-mutants did not significantly repress S- and M-opsin promoter transactivation, when compared to NR2E3 wild-type (p<0.01 by ANOVA). Third, the LBD-mutant p.R311Q repressed S- and M-opsin promoter activity similarly to wild-type NR2E3.
###end p 43
###begin title 44
Homology modeling of the NR2E3 homodimer DNA-binding complex
###end title 44
###begin p 45
###xml 162 170 162 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">figure 6</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Rastinejad1">[28]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Zhao1">[29]</xref>
###xml 393 394 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 598 607 594 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">figure 6A</xref>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s007">S7</xref>
###xml 616 618 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s008">S8</xref>
###xml 676 677 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 777 786 773 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">figure 6C</xref>
###xml 856 857 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 930 939 923 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">figure 6A</xref>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
To integrate the obtained functional data into related structural information, we performed homology modeling of the NR2E3 homodimer bound to a DR1 DNA sequence (figure 6). According to crystallographic data obtained for RXR/RXR and RXR/RAR dimers [28], [29], the NR2E3 homodimer bound to a DR1 is thought to interact through the alpha-helix of the T/A box of the 5'-monomer and the second Cys4-Zinc finger of the 3'-monomer. This model allowed us to evaluate potential functions of the residues that are mutated in patients. Residues R76, R97 and R104 are predicted to directly interact with DNA (figure 6A, S7 and S8). Residues R97 is, in addition, located in the second Cys4-Zinc finger forming the dimerization interface, whereas residue G88 is located in a loop close by (figure 6C). Notably, residue G56 is located in the beta-sheets of the first Cys4-Zinc finger and spatially segregated from the other analyzed mutations (figure 6A).
###end p 45
###begin title 46
Homology modeling of the NR2E3 homodimer DNA-binding complex.
###end title 46
###begin p 47
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 183 184 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 260 281 253 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s004">supplemental Figure 4</xref>
###xml 596 597 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 952 953 938 939 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
A) Ribbon view of the NR2E3 DBD homodimer bound to a DR1. Secondary structures of the NR2E3 DBD are shown as ribbons, i.e. starting from the N-terminus, 2 beta-sheets of the first Cys4 Zinc finger, and then the 3 alpha-helixes extending to the C-terminus (see supplemental Figure 4). The left NR2E3 DBD monomer is shown in yellow-orange, and the right one in blue-green colours. Residues mutated in patients are indicated and shown with sidechains. For the DNA double helix all side chains are shown. Zinc ions are shown as grey spheres. Residue G56 is located in the beta-sheets of the first Cys4 Zinc finger and spatially segregated from the other analyzed mutations. B) Molecular surface view of the NR2E3 homodimer DNA-binding complex. Molecular surface were represented in light-green for the left monomer and in light-blue for the right monomer. The alpha-helix of the T/A box of the left NR2E3 monomer (light green) interacts with the second Cys4 Zinc finger of the right NR2E3 monomer (light-blue). The DNA double helix is shown only as ribbon and colored in magenta. C) Close-up view of the dimerization interface. Residues involved in protein interactions are indicated and shown with sidechains. Figures were made with DeepView 4.0 program.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Angers1">[26]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Canals1">[30]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Terrillon1">[31]</xref>
In the present work, we analyzed by BRET2 the effect of disease-causing mutations located in the DBD of NR2E3. For all NR2E3 mutants we performed a BRET2 titration curve with a constant concentration of donor fluorochrome and an increased concentration of acceptor fluorochrome. This approach used in previous BRET studies [26], [30], [31] provides strong support to our proposed mechanism leading to ESCS or adRP syndromes.
###end p 49
###begin p 50
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 111 120 111 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s006">figure S6</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Schorderet1">[19]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Coppieters1">[20]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Gire1">[22]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 874 883 874 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figure 4B</xref>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s005">S5</xref>
###xml 972 976 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1179 1186 1179 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-opsin</italic>
###xml 1191 1198 1191 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 1277 1281 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
###xml 1343 1347 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1441 1450 1441 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 1452 1454 1452 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-</italic>
###xml 1459 1466 1459 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 1478 1487 1478 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figures 4</xref>
###xml 1492 1493 1492 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g005">5</xref>
###xml 1613 1621 1613 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1702 1709 1702 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 1714 1723 1714 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 1740 1743 1740 1743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
Like for all NRs, mutations in the DBD of NR2E3 abolished DNA-binding, as assessed by in vitro binding assays (figure S6). Absence of DNA-binding is therefore insufficient to explain the variety of clinical phenotypes observed in patients carrying mutations in this domain (reviewed in [19]). For instance, the adRP phenotype present in patients carrying the p.G56R mutation cannot be explained by a defect in DNA-binding alone [20]-[22]. Because NR2E3 had been shown to interact with CRX [4], we hypothesized that the transcriptional activity of CRX could be affected by structural changes present in NR2E3 mutant proteins. We therefore evaluated by BRET2 analysis whether NR2E3 DBD mutations affected the interaction with CRX causing phenotypic variations among patients. Remarkably, the adRP-linked p.G56R mutant protein interacted with CRX as did the wild-type protein (figure 4B and S5). This was in sharp contrast to all other ESCS-linked NR2E3 DBD mutant proteins, i.e. p.R76Q, p.R76W, p.G88V, p.R97H, p.R104Q and p.R104W. Consistent with this unique CRX interaction, the p.G56R mutant protein repressed in HEK293T-based transient transactivation assays the cone-specific S-opsin and M-opsin promoters, down to levels where CRX/NRL-mediated transactivation was affected [21]. All ESCS-linked NR2E3 DBD mutants not interacting with CRX, i.e. p.R76Q, p.R76W, p.G88V, p.R97H, p.104Q and p.104W, had similar transcriptional activities on rhodopsin, S- and M-opsin promoters (figures 4 and 5). This was somewhat different from a previous report where p.R76W and p.R97H mutant proteins differentially interacted in vitro with CRX as assessed by co-immunoprecipitation, but exerted the same effects on M-opsin and rhodopsin transactivation [4].
###end p 50
###begin p 51
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g007">figure 7</xref>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 720 728 <span type="species:ncbi:9606">patients</span>
The data presented here provide a novel molecular basis underlying adRP caused by the p.G56R mutant protein (figure 7). In this model the p.G56R mutant protein binds to CRX, hinders DNA-binding of the CRX/NR2E3-p.G56R heterodimer and acts as a repressor in trans. Because CRX is a master regulator of photoreceptor development, titrating active CRX protein levels is expected to have more profound effects than would the dominant negative activity towards NR2E3 wild type protein. In support of impaired CRX activity is not only the severe clinical phenotype of adRP, but also the mode of inheritance, i.e. one copy of the disease allele is sufficient to cause p.G56R-linked adRP, whereas the recessively inherited ESCS patients are either homozygous or compound heterozygous carriers of NR2E3 mutations.
###end p 51
###begin title 52
Hypotheses about transcriptional activities of NR2E3.
###end title 52
###begin p 53
###xml 76 85 76 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 131 150 131 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin and S-opsin</italic>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 696 705 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 844 849 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 785 793 <span type="species:ncbi:9606">patients</span>
A) In the "normal" situation, wild-type NR2E3 activates rod-specific genes (rhodopsin promoter) and represses cone-specific genes (M-opsin and S-opsin promoter) in concert with CRX and NRL. B') In ESCS patients, rhodopsin expression appears not to be affected in the presence of the p.R311Q LBD mutant protein. The molecular mechanism is unknown, but may involve posttranslational modifications or differential binding to cofactors. However, repression of cone genes is released, because interaction of the p.R311Q mutant protein with its co-repressor is impaired [4]. B'') In ESCS patients carrying mutations in the DBD, in the absence of DNA binding, NR2E3 does not potentiate CRX/NRL-mediated rhodopsin transactivation and does not repress cone-specific gene expression. C) In adRP patients, the p.G56R mutant protein acts as a repressor in trans of CRX-mediated photoreceptor-specfic gene expression. WT: wild type; 311Q: p.R311Q; mut*: p.R76Q, p.R104W; mutdegrees: p.R76W, p.G88V, p.R97H, p.R104Q; 56R: p.G56R.
###end p 53
###begin p 54
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 344 353 344 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g003">figure 3B</xref>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 565 570 <span type="species:ncbi:4932">yeast</span>
NR2E3/CRX interactions analyzed by BRET2 also showed the importance of a freely accessible N-terminal DBD of CRX to interact with NR2E3. Indeed, we observed a low energy transfer when the Renilla luciferase was fused to the N-terminal part of CRX (RLuc-Crx), in contrast to the Crx-RLuc fusion protein, where high energy transfer was observed (figure 3B). We cannot exclude that low BRET2 signals were due to conformational changes that affect the distance between the donor and the acceptor, but our results are consistent with previous co-immunoprecipitation and yeast two-hybrid assays, showing that CRX interacts with NR2E3 through its N-terminal DBD region [4].
###end p 54
###begin p 55
###xml 188 195 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 343 350 343 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 428 437 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figures 1</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g002">2</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g001">figure 1A</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kersten1">[32]</xref>
In addition to abolishing DNA-binding and modulating interaction with CRX (see above), modulation of NR2E3 homodimerization by mutations in the DBD could be an additional factor affecting in vivo NR2E3 activity. We therefore used BRET2 to investigate the dimerization potential of NR2E3 wild-type and mutant proteins. BRET2 provided the first in vivo evidence of NR2E3 homodimerization in transiently transfected HEK293T cells (figures 1 and 2). We did observe NR2E3 dimer formation in non-denaturing gel electrophoresis (figure 1A), but the signal corresponding to a NR2E3 dimer was weak with respect to the signal of the monomer. The influence of gel electrophoresis conditions on the oligomerization potential of another NR2 family member, the retinoid X receptor, had been studied previously in detail [32] and might underlie our observations.
###end p 55
###begin p 56
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figure 4A</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s004">S4</xref>
###xml 176 184 176 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 492 499 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">sesults</xref>
###xml 549 558 549 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 560 562 560 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-</italic>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S-opsin</italic>
###xml 600 601 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 688 696 688 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
The p.G56R mutant protein showed impaired dimerization with NR2E3 wild type protein as analyzed by BRET2 (figure 4A and S4). This result was in contradiction with our previous in vitro data where the p.G56R mutant protein dimerized with NR2E3 wild-type protein in EMSA analysis [21]. The new BRET2 data obtained in living cells is not in support of the previously suggested dominant negative activity of the p.G56R mutant protein, but the distinct interaction with CRX is consistent with the sesults previously obtained in transactivation assays on rhodopsin, M- and S-opsin promoter constructs. BRET2 analysis performed in living cells made it therefore possible to clarify our previous in vitro data and to propose this new disease mechanism [21].
###end p 56
###begin p 57
###xml 98 108 98 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g004">figures 4A</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">6C</xref>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 603 612 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s008">figure S8</xref>
###xml 858 859 854 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 873 882 869 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g006">figure 6C</xref>
Consistent with the observed impaired dimerization, R97 is located in the dimerization interface (figures 4A and 6C). Interestingly, when DNA-interacting residues R76 and R104 are mutated into Q or W, opposing effects on dimerization were observed by BRET2. Mutant proteins p.R76W and p.R104Q showed impaired homodimerization, but not p.R76Q and p.R104W mutant proteins. Mutating R76 abolishes two hydrogen bonds with DNA and the presence of a bulky hydrophobic side chain in the p.R76W mutant protein might displace the C-terminal alpha  helix of the T/A box that forms the DBD dimerization interface (figure S8). In contrast, the side chain of residue 104 is directed towards the inside of the DBD, leaving intact the dimerization interfaces. The dramatic effect of the p.G88V mutation on NR2E3-dimerization could be due to a displacement of the second Cys4-Zinc finger (figure 6C). However, in the absence of crystallographic data, these interpretations remain speculative.
###end p 57
###begin p 58
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR2E3</italic>
###xml 266 274 266 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007379-g007">Figure 7</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
###xml 375 378 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Cheng2">[7]</xref>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR2E3</italic>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Onishi1">[33]</xref>
In conclusion, BRET2 has proven to be a valuable and reliable method to analyze NR2E3 and CRX protein-protein interactions. This functional analysis in living cells lead to further understanding of potential disease mechanisms in NR2E3-linked retinal degenerations. Figure 7 summarized hypothetic mechanisms supported by our results (this study and [21]) and others studies ([4], [7]). All analyzed mutations in the DBD disrupt DNA binding, but the persistent association with CRX causes the adRP-linked p.G56R mutant protein to act as a repressor of CRX in trans. The clinical phenotype resulting from the other NR2E3 mutations in the DBD are similar to those observed in presence of mutations in the LBD, i.e. ESCS. We have previously shown in heterologous transactivation assays that repression of cone-specific promoters by the LBD mutant protein p.R311Q was impaired in presence of the co-repressor atrophin [33]. The absence of NR2E3 repressor function on cone-specific promoters very likely causes ESCS, and at least three different molecular mechanisms may be involved: 1) absence of NR2E3 protein because of nonsense mutations and aberrant splicing; 2) absence of DNA binding because of mutations in the DBD; 3) impaired corepressor binding because of mutations in the LBD.
###end p 58
###begin p 59
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Onishi1">[33]</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR2E3</italic>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
Recently, the dual function of NR2E3 in mature rods, i.e. repression of cone-specific genes and activation of several rod-specific genes, has been shown to be regulated by the E3 small ubiquitin-related modifier (SUMO) ligase PIAS3 (protein inhibitor of activated Stat3) [33]. PIAS3-dependent SUMOylation converts NR2E3 into a potent repressor of cone-specific genes. Whether NR2E3 mutations occurring in patients affect SUMOylation or other posttranslational modifications and this, in turn, affects DNA binding or protein-protein interactions, remains elusive and will require further studies.
###end p 59
###begin title 60
Materials and Methods
###end title 60
###begin title 61
Expression vectors
###end title 61
###begin p 62
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 564 572 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s009">Table S1</xref>
###xml 927 928 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1062 1063 1060 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 301 306 <span type="species:ncbi:9606">human</span>
Bioluminescence Resonance Energy Transfer (BRET2) vectors, encoding the humanized Renilla luciferase (hRluc) and the humanized green fluorescent protein 2 (hGFP2) were purchased from PerkinElmer-BioSignal (Montreal, QC, Canada). The plasmids pcDNA3.1/HisC-hNR2E3 and pcDNA3.1/HisC-hCRX expressing the human NR2E3 and CRX, respectively, were kindly provided by Shiming Chen [4]. To obtain all NR2E3 mutants we performed mutagenesis according to the QuikChange(R)II Site-Directed Mutagenesis Kit. Briefly, pcDNA3.1/HisC-hNR2E3 was amplified with oligos described in Table S1 using PfuUltra polymerase (Stratagene; Cedar Creek, TX). For RLuc-fusion proteins, PCR amplification (oligonucleotides available on request) of wild-type and mutants NR2E3, and CRX were subcloned, in the hRluc-C1 or -N3 vectors, respectively. We obtained the Rluc-NR2E3, NR2E3-Rluc, Rluc-Crx and Crx-Rluc vectors, which express chimeric proteins. For GFP2-fusion proteins, PCR amplification (oligonucleotides available on request) of wild-type and mutants NR2E3 were subcloned, in the hGFP2-C3 or -N3 vectors, respectively. We obtained the GFP-NR2E3 and NR2E3-GFP vectors, which express chimeric proteins. All constructs were verified by nucleotide sequencing.
###end p 62
###begin title 63
Cell Culture Condition and Transfection
###end title 63
###begin p 64
###xml 93 94 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 273 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 373 374 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 657 658 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic kidney (HEK) 293T cells were cultured at 37degreesC in an atmosphere of 5% CO2, in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, 100 U/ml penicillin and 100 microg/ml streptomycin (#31330, Invitrogen AG, Basel, Switzerland). For BRET2 analyses, one day prior to the experiment, cells were seeded in 60-mm cell culture plates at 0.8x106 cells. One day after plating, each 60-mm plate was transfected with the Calcium Phosphate method (ProFection(R), Promega, Madison, WI) with 0.5 microg to 3 microg of plasmid depending of the experiment. The cells were harvested 48 h after transfection prior to Western blot and BRET2 analysis.
###end p 64
###begin title 65
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
BRET2 Assays and Fluorescence Imaging
###end title 65
###begin p 66
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 930 931 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 946 947 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1178 1179 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1185 1186 1181 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1334 1337 1330 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 1407 1408 1401 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1499 1501 1488 1490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex</sub>
###xml 1532 1534 1516 1518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">em</sub>
Transfected HEK293T cells were washed with phosphate-buffered saline (PBS), detached with trypsin/EDTA, and then washed twice with Dulbecco's Phosphate-Buffered Saline (D-PBS, GIBCO, Invitrogen AG, Basel, Switzerland). Aliquots of 105 cells were distributed in black 96-well microplates (Optiplate, PerkinElmer Life Sciences/Packard Biosciences) for fluorescence quantification. Filter sets were 485 nm for GFP2 excitation and 515 nm for emission. Cells expressing BRET2 donor alone (RLuc) were used to determine fluorescence background. Aliquots of cells expressing same levels of fluorescence were distributed in white 96-well microplates (Optiplate, PerkinElmer Life Sciences/Packard Biosciences) for luminescence assay. The luciferase substrate Coelenterazine h, DeepBlueC, (PerkinElmer/Biosignal; Montreal, QC) was added at a final concentration of 5 microM. Filter sets were 410 nm for luciferase emission and 515 nm for GFP2 emission. BRET2 ratio is defined as: [emission at 515 nm)/(emission 410 nm)] - Cf, where Cf corresponds to (emission at 515 nm)/(emission 410 nm) for the control experiment with Rluc construct expressed with the concerned protein fused to the GFP2. BRET2 ratio is expressed as raw data in experiments showing all negative controls. Emitted fluorescence and luminescence were measured using the Envision(R) microplates reader (PerkinElmer/Biosignal, QC, Montreal). For the GFP2 fluorescence imaging, HEK293T cells were analyzed under microscope with excitation (lambdaex = 485 nm) and emission (lambdaem = 515 nm) filters.
###end p 66
###begin title 67
Western Blot Analysis
###end title 67
###begin p 68
###xml 791 797 <span type="species:ncbi:9986">rabbit</span>
HEK293T cells were cultured as described above. Then, they were washed in PBS, suspended in 100 microl sample buffer containing 20 mM Hepes, 0.5% Tween, phosphatase inhibitors cocktail 1 and 2 (Sigma #p2850, #p5726; St-Louis, MO) and Complete(R) protease inhibitors (Roche Applied Science, Rotkreuz, Switzerland). Cells were lysed with 3 successive freezing-thawing cycles. The detergent-insoluble material was pelleted by centrifugation at 15,000 rpm for 5 min at 4degreesC. The supernatant containing protein cell lysates (30 microg) were used for western blotting. For Western blot analysis, proteins were electrically transferred to PVDF filters and incubated with anti-NR2E3 (Chemicon; Millipore AG, Switzerland) or anti-GFP (Sigma-Aldrich; St.Louis, MO, USA). Secondary antibody, anti-rabbit-HRP (Amersham Biosciences; Otelfingen, Switzerland), was used to detect protein expression. Immune complexes were detected by chemiluminescence using LumiGLO (Amersham Biosciences, Otelfingen, Switzerland).
###end p 68
###begin title 69
Transcriptional Activity
###end title 69
###begin p 70
###xml 455 464 453 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rhodopsin</italic>
###xml 486 489 484 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 491 498 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-opsin</italic>
###xml 521 524 519 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
###xml 554 557 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Peng1">[4]</xref>
HEK293T cells were cultured as described above. Cells were plated in 12-well plates and transfected at a confluence of 30% with the Calcium Phosphate method (ProFection(R), Promega, Madison, WI). Per well, 30 ng of each of the expression vectors pcDNA3.1/HisC-hNR2E3 (wild-type, p.G56R, p.R76Q, p.R76W, p.G88W, p.R97H, p.R104Q, p.R104W and p.R311Q), pcDNA3.1/HisC-hCRX and pMT-NRL were used, together with 500 ng of the luciferase reporter constructs for rhodopsin promoter (BR225-Luc) [4], M-opsin promoter (Mop250-Luc) [4] or S_opsin promoter (opn1sw) [4]. As internal standard, 50 ng of plasmid CMVbeta (Clontech, Moutain View, CA) encoding beta-galactosidase was used. To keep the total transfected DNA quantity constant, appropriate quantities of pcDNA3.1/HisC empty vector was added in all experiments. Enzymatic activities were assessed with Luciferase Assay System (Promega, Madison, WI) and standard beta-Gal assay.
###end p 70
###begin title 71
Homology modeling
###end title 71
###begin p 72
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Schwede1">[34]</xref>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Arnold1">[36]</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
Homology modeling was performed in project mode on the SWISS-MODEL server () using DeepView 4.0 program [34]-[36]. Amino acids 47-123 of human NR2E3 (SwissProt Acc. No. Q9Y5X4) spanning the DBD were modeled, using crystallographic data of COUP-TF DBD (PDB Acc. No. 2EBL), RXR homodimer on DR1 DNA sequence (PDB Acc. No. 1BY4) and RXR/RAR heterodimer on DR1 DNA sequence (PDB Acc. No. 1DSZ) as templates.
###end p 72
###begin title 73
Statistical Analysis
###end title 73
###begin p 74
###xml 141 142 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All results were expressed as means+/-SEM of the indicated number of experiments. Statistical significance was calculated with the Student's t test and ANOVA, using Prism 4.0.2 (GraphPad Software; La Jolla, CA).
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 373 374 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 565 566 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 636 637 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 854 855 830 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1018 1019 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
BRET2 analysis of NR2E3 homodimerization and interaction with CRX. Donor saturation curves were obtained by measuring BRET2 ratio in the presence of fixed quantities of donor and increasing amounts of acceptor. In panel A, HEK293T cells were transiently transfected with 3 microg of RLuc or NR2E3-RLuc vectors, and an increased concentration (0.5 microg to 3 microg) of GFP2-NR2E3 vector. While in panel B, HEK293T cells were transiently transfected with 3 microg of RLuc or Crx-RLuc vectors and with an increased concentration (0.5 microg to 2 microg) of NR2E3-GFP2 vector. We pooled 5 to 6 different experiments and expressed the BRET2 ratio ([emission at 515 nm)/(emission 410 nm)] - Cf, where Cf corresponds to (emission at 515 nm)/(emission 410 nm) for the control experiment with Rluc construct expressed with the concerned protein fused to the GFP2) in function of (GFP/GFPdegrees)/RLuc where GFPdegrees correspond to the luminescence of the acceptor in cells expressing the BRET donr alone (RLuc). In both BRET2 experiments we reach a plateau with high acceptor concentration.
###end p 76
###begin p 77
(1.03 MB EPS)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Nuclear localization of NR2E3 wild-type and mutant proteins. HEK293T cells were transiently transfected with GFP2-NR2E3 expression vectors. Fluorescence imaging under a Zeiss (Axiovert 200) inverted microscope was used to detect GFP2 fluorescence. Wild-type and mutant NR2E3 proteins were correctly localized to the nucleus.
###end p 79
###begin p 80
(3.73 MB EPS)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 239 241 239 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 303 306 303 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 484 486 484 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 492 494 492 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 698 699 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 706 709 704 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 713 714 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 740 741 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 791 792 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 806 807 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 813 814 811 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 851 858 849 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 885 886 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 892 894 890 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
Comparable expression levels of NR2E3 wild-type and mutant proteins in transiently transfected HEK293 cells. (A) HEK293T cells were transiently transfected with vectors expressing the wild-type NR2E3 (WT) fused to renilla luciferase (NR2E3WT-RLuc) and with mutants of NR2E3 fused to the GFP2 (GFP2-NR2E3MUT). Fluorescence of the GFP2 was measured to ensure an equal expression of GFP2 alone and GFP2-NR2E3x chimera proteins in each condition. Results were expressed as % of GFP2-NR2E3WT/NR2E3WT-RLuc and as a mean+/-SEM of 3 experiments. (B) HEK293T cells were transiently transfected with vectors expressing the CRX fused to renilla luciferase (Crx-RLuc) and with mutants of NR2E3 fused to the GFP2 (NR2E3MUT-GFP2). Fluorescence of the GFP2 was measured to ensure an equal expression of GFP2 alone and GFP2-NR2E3x chimera proteins in each condition. Results were expressed as % of GFP2-NR2E3WT/Crx-RLuc and as a mean+/-SEM of 2 experiments.
###end p 82
###begin p 83
(1.26 MB EPS)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 181 183 177 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 279 280 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 285 286 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 292 294 284 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 301 302 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 308 311 300 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
BRET2 titration curves of NR2E3 mutants in the NR2E3 dimerization. For each NR2E3 mutant, we transfected 293T cells with 2 I(1/4)g of RLuc alone (RLuc) or fused to NR2E3 (RLuc-NR2E3WT) and an increasing amount (0.5 to 4 I(1/4)g) of the NR2E3 wild-type or mutants fused to the GFP2 (GFP2-NR2E3WT or GFP2-NR2E3MUT). Sigmoidal regression curves were performed for all graphs.
###end p 85
###begin p 86
(1.25 MB EPS)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 268 269 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 276 278 268 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sub>
###xml 282 283 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 292 295 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MUT</sub>
###xml 299 300 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
BRET2 titration curve of NR2E3 mutants in NR2E3/CRX interation. For each NR2E3 mutant we transfected 293T cells with 2 I(1/4)g of RLuc alone (RLuc) or fused to CRX (CRX-RLuc) and an increasing amount (0.5 to 4 I(1/4)g) of the NR2E3 wild-type or mutant fused to the GFP2 (NR2E3WT-GFP2 or NR2E3MUT-GFP2). Sigmoidal regression curves were performed for all graphs.
###end p 88
###begin p 89
(2.03 MB EPS)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kobayashi1">[1]</xref>
###xml 847 851 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Escher1">[21]</xref>
###xml 1088 1122 1084 1118 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTTAAAAGTCAAAAGTCAACTTCCAA-3&#8242;</named-content>
###xml 1140 1174 1136 1170 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCCGTTGGAAGTTGACTTTTGACTTTT-3&#8242;</named-content>
###xml 1235 1237 1225 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1721 1723 1695 1697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Mutations in the DBD impair DNA binding. NR2E3 wild-type and mutants proteins were in vitro transcribed/translated in reticulocyte lysates (TNT; Promega).; In vitro DNA-binding of NR2E3 proteins was tested on a radiolabeled consensus DR1 response element [1] with a 100-fold excess of either non-specific (-) or specific (+) competitor oligonucleotides. One I(1/4)l of programmed reticulocyte lysate was used per binding reaction. Transcription/translation efficiency was tested by western blot analysis (data not shown). The migration of the complex formed by binding of the NR2E3 dimer to the probe is indicated by a black arrow. DNA binding is only detected in the presence of wild-type NR2E3 and the LBD-mutant p.R311Q (low level of detection was observed for the p.R311Q mutant in this experiment, but higher exposition and published studies [21] showed clearly a DNA-binding for the p.R311Q mutant). All DBD mutants, i.e. p.G56R, p.R76Q, p.R76W, p.G88V, p.R97H, p.R104Q and p.R104W, did not bind to DNA. The radiolabeled probe was obtained by annealing oligonucleotides NR2E3REfor (5'-CCTTTAAAAGTCAAAAGTCAACTTCCAA-3') and NR2E3RErev (5'-TTCCGTTGGAAGTTGACTTTTGACTTTT-3'). Radiolabeling by Klenow fill-in with 30 I(1/4)Ci of [I+/--32P]dATP (3000 Ci/mmol) (Hartmann Analytik, Braunschweig) and subsequent probe purification on Sephadex G-50 columns was according to manufacturers instructions (Roche, Basel, Switzerland). DNA-binding reactions were carried out in 20 I(1/4)l of 10 mM Tris (pH 7.5), 160 mM KCl, 1 mM dithiothreitol (DTT), 10% glycerol, 10 I(1/4)g of sonicated salmon sperm DNA (Roche), 2 I(1/4)g of poly(dI-dC) and 1 I(1/4)l of programmed reticulocyte lysate. After a 15-min incubation on ice, 1 ng of 32P-labeled probe was added, and incubations were continued for an additional 15 min at room temperature. DNA-protein complexes were separated from free probe on a native 4% polyacrylamide gel in 0.5 x Tris/borate/EDTA (TBE) buffer. Gels were dried and revealed by phosphorimaging (GE Healthcare, Piscataway, NJ).
###end p 91
###begin p 92
(1.73 MB EPS)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 642 646 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Storez1">[27]</xref>
###xml 648 652 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Rastinejad1">[28]</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Amino acid sequence alignment of human NR2E3 (PNR) and NR2B1 (RXRI+/-) DNA-binding domains (DBDs). The NR2E3 DBD (residues 47-123 of SwissProt Acc. No. Q9Y5X4) exhibits a sequence identity of 57.1% (44 residues) and a sequence similarity of 80.5% (62 residues) with the RXRI+/-DBD (residues 135-210 of SwissProt Acc. No. P19793). The main regions of the DBD, i.e. the two Cys4 Zn-fingers and the so-called T/A box, are indicated above the sequence alignment. Disease-causing mutations are indicated above the NR2E3 sequence. Given the high sequence homology, the structural data obtained for RXRI+/- were also indicated on the NR2E3 sequence [27], [28]. Residues directly interacting with DNA are highlighted in yellow. Residues directly involved in protein-protein interactions in the RXR homodimer are highlighted in blue. Residues involved in both DNA-binding and RXR dimerization are highlighted in grey. The I+/--helical regions are underlined. The I+/--helical region extending from the C-terminus of the first Cys4 Zn-finger is called recognition helix and contains the P-box responsible for DNA-binding specificity. The residues of the P-box are shown in italics. In the N-terminus of the second Cys4 Zn-finger, the residues of the D-box involved in dimerization are also shown in italics. A second I+/--helical region extends from the C-terminus of the second Cys4 Zn-finger. The third I+/--helix is a part of the so-called T/A box that extends beyond the region for which crystallographic data are available. Sequences were aligned with the CLUSTAL W 2.0 algorithm. Polar residues are shown in green, non-polar residues in red, basic residues in magenta, and acidic residues in blue. Below the sequence alignment, (*) denotes sequence identity, (:) denotes conserved substitutions, and, (.) denotes semi-conserved substitutions.
###end p 94
###begin p 95
(1.00 MB EPS)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Canals1">[30]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007379-Kersten1">[32]</xref>
###xml 832 853 817 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007379.s004">supplemental Figure 4</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
Mutation analysis by homology modeling of the NR2E3 homodimer DNA-binding complex. Amino acids 47-123 of human NR2E3 (SwissProt Acc. No. Q9Y5X4) were used for homology modelling on the SWISS-MODEL server with DeepView program () [30]-[32]. Crystallographic data of COUP-TF DBD (PDB Acc. No. 2EBL), RXR homodimer on DR1 DNA sequence (PDB Acc. No. 1BY4) and RXR/RAR heterodimer on DR1 DNA sequence (PDB Acc. No. 1DSZ) were used as templates. Secondary structures of the NR2E3 DBD monomer are shown as ribbons, i.e. starting from the N-terminus, 2 beta-sheets of the first Cys4 zinc finger in green-yellow, the alpha-helix located in C-terminus of the first Cys4 zinc finger in yellow, the second alpha-helix located in C-terminus of the second Cys4 zinc finger in orange and the C-terminal alpha-helix of the T/A box in red (see also supplemental Figure 4). Residues p.R76 (left panels) and p.R104 (right panels) are shown with sidechains. For the DNA double helix all side chains are shown. Zinc ions are shown as small grey spheres. Residue p.R76 (left, upper panel) is located at the very C-terminus of the alpha-helix located in C-terminus of the first Cys4 zinc finger and directly contacts DNA through two hydrogen bonds (green dotted line). Both p.R76Q and p.R76W mutations disrupt hydrogen bond formation (left, middle and lower panels). The most favoured rotamers of the mutated residues all point towards the C-terminal a-helix of the T/A box. The bulky hydrophobic Trp sidechain might therefore impede dimerization. Residue p.104 (right, upper panel) is located in the middle of the alpha-helix located in C-terminus of the second Cys4 zinc finger. The sidechain points towards the inside of the protein, also in presence of the p.R104Q and p.R104W mutations (left, middle and lower panels).
###end p 97
###begin p 98
(5.25 MB EPS)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
PCR primers used for NR2E3 mutagenesis.
###end p 100
###begin p 101
(1.43 MB EPS)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
We thank Martine Emery, Nathalie Voirol, Loriane Moret and Tatiana Favez for technical help, Dr. Lorenza Bordoli (Swiss Institute of Bioinformatics) for expert advice on homology modelling, and Dr Sandra Cottet and Dr Nathalie Allaman-Pillet for helpful discussions and critical reading of the manuscript. The plasmids pcDNA3.1/HisC-hNR2E3 and pcDNA3.1/HisC-hCRX were kindly provided by Shiming Chen (Washington University, St-Louis, MO).
###end p 103
###begin title 104
References
###end title 104
###begin article-title 105
Identification of a photoreceptor cell-specific nuclear receptor.
###end article-title 105
###begin article-title 106
Regulation of photoreceptor gene expression by Crx-associated transcription factor network.
###end article-title 106
###begin article-title 107
The transcription factor Nr2e3 functions in retinal progenitors to suppress cone cell generation.
###end article-title 107
###begin article-title 108
The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes.
###end article-title 108
###begin article-title 109
The rod photoreceptor-specific nuclear receptor Nr2e3 represses transcription of multiple cone-specific genes.
###end article-title 109
###begin article-title 110
In vivo function of the orphan nuclear receptor NR2E3 in establishing photoreceptor identity during mammalian retinal development.
###end article-title 110
###begin article-title 111
Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors.
###end article-title 111
###begin article-title 112
The nuclear receptor superfamily: the second decade.
###end article-title 112
###begin article-title 113
###xml 46 56 <span type="species:ncbi:7227">Drosophila</span>
Spatial control of the gap gene knirps in the Drosophila embryo by posterior morphogen system.
###end article-title 113
###begin article-title 114
Origins and evolutionary diversification of the nuclear receptor superfamily.
###end article-title 114
###begin article-title 115
###xml 21 31 <span type="species:ncbi:7227">Drosophila</span>
Relationship between Drosophila gap gene tailless and a vertebrate nuclear receptor Tlx.
###end article-title 115
###begin article-title 116
The orphan nuclear receptor Tlx regulates Pax2 and is essential for vision.
###end article-title 116
###begin article-title 117
Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.
###end article-title 117
###begin article-title 118
SWS (blue) cone hypersensitivity in a newly identified retinal degeneration.
###end article-title 118
###begin article-title 119
###xml 43 48 <span type="species:ncbi:9606">human</span>
The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration.
###end article-title 119
###begin article-title 120
Mutation analysis of NR2E3 and NRL genes in Enhanced S Cone Syndrome.
###end article-title 120
###begin article-title 121
Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.
###end article-title 121
###begin article-title 122
Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
###end article-title 122
###begin article-title 123
NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
###end article-title 123
###begin article-title 124
Recurrent mutation in the first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa.
###end article-title 124
###begin article-title 125
Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family.
###end article-title 125
###begin article-title 126
The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa.
###end article-title 126
###begin article-title 127
Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET).
###end article-title 127
###begin article-title 128
A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.
###end article-title 128
###begin article-title 129
Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET).
###end article-title 129
###begin article-title 130
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
###end article-title 130
###begin article-title 131
Homo- and hetero-oligomerization of beta-arrestins in living cells.
###end article-title 131
###begin article-title 132
Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.
###end article-title 132
###begin article-title 133
Structural elements of an orphan nuclear receptor-DNA complex.
###end article-title 133
###begin article-title 134
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.
###end article-title 134
###begin article-title 135
Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with {beta}-arrestin and their trafficking patterns.
###end article-title 135
###begin article-title 136
Retinoid X receptor alpha forms tetramers in solution.
###end article-title 136
###begin article-title 137
Pias3-dependent SUMOylation directs rod photoreceptor development.
###end article-title 137
###begin article-title 138
SWISS-MODEL: An automated protein homology-modeling server.
###end article-title 138
###begin article-title 139
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.
###end article-title 139
###begin article-title 140
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.
###end article-title 140
###begin p 141
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 141
###begin p 142
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: PE and DFS are supported by the Swiss National Foundation (SNF) grant #3100A0-122269/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 142

